AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?

AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?

The cytoprotective effects of MK-801 and NBQX, selective N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor antagonists, respectively, were compared both singularly and in combination in models of transient severe forebrain and transient focal c...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Buchan, A, Lesiuk, H, Barnes, K, Li, H, Huang, Z, Smith, K, Xue, D
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	1993

Παρόμοια τεκμήρια

Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.
ανά: Xue, D, κ.ά.
Έκδοση: (1994)

DELAYED TREATMENT WITH AMPA BUT NOT NMDA GLUTAMATE ANTAGONISTS REDUCES NEOCORTICAL INFARCTION
ανά: Xue, D, κ.ά.
Έκδοση: (1992)

POSTISCHEMIC TREATMENT WITH AMPA, BUT NOT NMDA, ANTAGONISTS PREVENTS CA1 NEURONAL INJURY
ανά: Li, H, κ.ά.
Έκδοση: (1992)

The rise and fall of NMDA antagonists for ischemic stroke.
ανά: Hoyte, L, κ.ά.
Έκδοση: (2004)

NMDA antagonists: their role in neuroprotection.
ανά: Small, D, κ.ά.
Έκδοση: (1997)

NMDA antagonists: their role in neuroprotection.
ανά: Small, D, κ.ά.
Έκδοση: (1997)

Do NMDA antagonists prevent neuronal injury? No.
ανά: Buchan, A
Έκδοση: (1992)

Promises and Pitfalls of NMDA Receptor Antagonists in Treating Violent Aggression
ανά: Caitlyn J. Bartsch, κ.ά.
Έκδοση: (2022-06-01)

The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke.
ανά: Buchan, A, κ.ά.
Έκδοση: (1992)

Neuroprotection, excitotoxicicity and nmda antagonists
ανά: RUBENS JOSÉ GAGLIARDI
Έκδοση: (2000-06-01)

Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted?
ανά: Buchan, A
Έκδοση: (1990)

INVERSE AGONISTS: MORE THAN JUST ANTAGONISTS?
ανά: R. N. Alyautdin, κ.ά.
Έκδοση: (2022-06-01)

Delayed AMPA receptor blockade reduces cerebral infarction induced by focal ischemia.
ανά: Buchan, A, κ.ά.
Έκδοση: (1991)

NMDA Receptor Antagonists for Treatment of Depression
ανά: Zeynep Ates-Alagoz, κ.ά.
Έκδοση: (2013-04-01)

Synergistic neuroprotective effects by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitors in global cerebral ischaemia.
ανά: Hicks, C, κ.ά.
Έκδοση: (1999)

CP-465,022, a selective noncompetitive AMPA receptor antagonist, blocks AMPA receptors but is not neuroprotective in vivo.
ανά: Menniti, F, κ.ά.
Έκδοση: (2003)

NEUROPROTECTIVE PROFILE OF FPL-15896AR, A NOVEL UNCOMPETITIVE NMDA ANTAGONIST
ανά: Murray, R, κ.ά.
Έκδοση: (1995)

Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury.
ανά: Li, H, κ.ά.
Έκδοση: (1993)

HYPOTHERMIA BUT NOT NMDA RECEPTOR ANTAGONIST MK-801 ATTENUATES NEURON DAMAGE - ARE THE RESULTS CONCLUSIVE - REPLY
ανά: Buchan, A, κ.ά.
Έκδοση: (1992)

NMDA receptor antagonists in the treatment of neurological diseases
ανά: I. S. Preobrazhenskaya
Έκδοση: (2020-10-01)

PSYCHOPHARMACOLOGICAL PROFILE OF THE NMDA RECEPTOR ANTAGONIST MK-801
ανά: Iversen, S, κ.ά.
Έκδοση: (1987)

Cold Pain Threshold and Role of NMDA Receptor Antagonists
ανά: Poroshat Nazemi, κ.ά.
Έκδοση: (2019-01-01)

Montelukast: More than a Cysteinyl Leukotriene Receptor Antagonist?
ανά: Gregory R. Tintinger, κ.ά.
Έκδοση: (2010-01-01)

NMDA receptor antagonists can enhance or impair learning performance in animals.
ανά: Mondadori, C, κ.ά.
Έκδοση: (1989)

NMDA receptor antagonists in the treatment of patients with vascular cognitive imprairments
ανά: I.S. Preobrazhenskaya
Έκδοση: (2014-10-01)

Is Memantine Effective as an NMDA Receptor Antagonist in Adjunctive Therapy for Schizophrenia?
ανά: Tetsuro Kikuchi
Έκδοση: (2020-07-01)

NMDA receptor antagonists as potential therapy in cerebellar degenerative disorders
ανά: Olga S. Belozor, κ.ά.
Έκδοση: (2022-06-01)

Modulation of functional EEG networks by the NMDA antagonist nitrous oxide.
ανά: Levin Kuhlmann, κ.ά.
Έκδοση: (2013-01-01)

NMDA receptor antagonist ketamine impairs feature integration in visual perception.
ανά: Julia D I Meuwese, κ.ά.
Έκδοση: (2013-01-01)

Agonist hold Antagonist Protocol versus Antagonist Protocol in Intracytoplasmic Sperm Injection for Infertile Patients with Polycystic Ovary Syndrome
ανά: Hazem H. Ahmed, κ.ά.
Έκδοση: (2022-01-01)

Safety of Cholinesterase Inhibitors and NMDA Receptors Antagonists for the Treatment of Patients with Dementia
ανά: A. P. Pereverzev, κ.ά.
Έκδοση: (2019-12-01)

Effects of Memantine, an NMDA Antagonist, on Metabolic Syndromes in Female NMRI Mice
ανά: Naser Osanloo, κ.ά.
Έκδοση: (2015-10-01)

NMDA Receptor Antagonist Attenuates Bleomycin-Induced Acute Lung Injury.
ανά: Yang Li, κ.ά.
Έκδοση: (2015-01-01)

Behavioral consequences of NMDA antagonist-induced neuroapoptosis in the infant mouse brain.
ανά: Carla M Yuede, κ.ά.
Έκδοση: (2010-06-01)

NMDA-receptor antagonists disrupt the formation of the auditory space map in the mammalian superior colliculus.
ανά: Schnupp, J, κ.ά.
Έκδοση: (1995)

Narrow temporal therapeutic window for NMDA antagonist protection against focal cerebral ischaemia
ανά: Gary K. Steinberg, κ.ά.
Έκδοση: (1995-04-01)

Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus
ανά: F. A. Zeiler
Έκδοση: (2015-01-01)

NMDA Receptor Antagonist Memantine Ameliorates Experimental Autoimmune Encephalomyelitis in Aged Rats
ανά: Biljana Bufan, κ.ά.
Έκδοση: (2024-03-01)

NMDA Receptor-Antagonistic Properties of Hyperforin, a Constituent of St. John’s Wort
ανά: Vikas Kumar, κ.ά.
Έκδοση: (2006-01-01)

Ammonia-mediated LTP inhibition: Effects of NMDA receptor antagonists and l-carnitine
ανά: Yukitoshi Izumi, κ.ά.
Έκδοση: (2005-11-01)